These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2846400)

  • 61. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Resolution and quantitation of apolipoproteins A-I and A-II from human high-density lipoprotein by size exclusion high-performance liquid chromatography.
    Young PM; Boehm TM; Brown JE
    J Chromatogr; 1984 Nov; 311(1):79-92. PubMed ID: 6440900
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of the binding of thyroxine to high density lipoproteins and apolipoproteins A-I.
    Benvenga S; Cahnmann HJ; Gregg RE; Robbins J
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1067-72. PubMed ID: 2498379
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
    Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
    Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Lake-Bakaar G; Mazzoccoli V; Ruffini L
    Dig Dis Sci; 2002 Jul; 47(7):1644-8. PubMed ID: 12141830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
    Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
    Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
    Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lectin binding patterns in normal liver, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. An immunohistochemical and immunoelectron microscopic study.
    Murakami I; Sarker AB; Hayashi K; Akagi T
    Acta Pathol Jpn; 1992 Aug; 42(8):566-72. PubMed ID: 1333146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Expression of MCP/CCR2 in patients of hepatocellular carcinoma and liver cirrhosis].
    Fang N; Fan X; Zhang XS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):553-4. PubMed ID: 19912695
    [No Abstract]   [Full Text] [Related]  

  • 71. Human proapolipoprotein A-I: development of an antibody to the propeptide as a probe of apolipoprotein A-I biosynthesis and processing.
    Hospattankar AV; Fairwell T; Appella E; Meng M; Brewer HB
    Biochem Biophys Res Commun; 1987 Nov; 149(1):289-96. PubMed ID: 3120726
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apolipoprotein AI, AII, and AIV isoforms in plasma determined by automated isoelectric focusing with PhastSystem and immunofixation.
    Schaefer JR; Hackler R; Brand S; Schwarz S; Kleine TO; Steinmetz A
    Clin Chem; 1995 Jan; 41(1):76-81. PubMed ID: 7813085
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Expression of p21 in hepatocellular carcinoma and liver cirrhosis and its relation with HBV infection].
    Ren CS
    Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):88-90. PubMed ID: 1655296
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Blood clearance rate as an adjunct to the 198 Au hepatoscan.
    Bahk YW
    Br J Radiol; 1972 Jan; 45(529):24-30. PubMed ID: 4332734
    [No Abstract]   [Full Text] [Related]  

  • 75. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isolation, characterization and quantification of apolipoproteins A-1 and B of the Golden Syrian hamster (Mesocricetus auratus) and modification of their levels by dietary cholesterol.
    Burton PM; Chiou YM
    Comp Biochem Physiol B; 1989; 92(4):667-73. PubMed ID: 2498030
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carbohydrate changes in liver disease.
    Sherlock S
    Am J Clin Nutr; 1970 Apr; 23(4):462-6. PubMed ID: 4315010
    [No Abstract]   [Full Text] [Related]  

  • 78. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
    Zhou XD; DeTolla L; Custer RP; London WT
    Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.
    Kouroumalis E; Skordilis P; Thermos K; Vasilaki A; Moschandrea J; Manousos ON
    Gut; 1998 Mar; 42(3):442-7. PubMed ID: 9577356
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Processing of proapolipoprotein AI requires specific conformation.
    Stoffel W; Niedel B
    Biol Chem Hoppe Seyler; 1985 Feb; 366(2):181-7. PubMed ID: 3921042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.